Autism Spectrum Disorder Trial, Recruiting (NCT06127472)

Autism Spectrum Disorder Trial, Recruiting NCT06127472 Sponsor: Tilburg University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06127472 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are at least 55 years old.
People who have been diagnosed with Autism Spectrum Disorder (ASD), or received a probable diagnosis of ASD, by a specialist team following Dutch clinical guidelines, confirmed through a recognised diagnostic interview for ASD in adults.

Who may not be able to join:

People who have another mental health condition that currently requires urgent treatment and would significantly interfere with participating in a group-based program (for example, psychosis).
People who have a major condition affecting memory, thinking, or brain function (for example, dementia or acquired brain injury).
People who have a substance use disorder that requires a medically supervised detoxification program.
People whose IQ has been assessed as below 70.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arjan Videler, Dr., Tilburg University, GGz Breburg

Phone: +3188-0162336

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06127472

Sponsor: Tilburg University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +3188-0162336

More information: https://clinicaltrials.gov/study/NCT06127472

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are at least 55 years old.
People who have been diagnosed with Autism Spectrum Disorder (ASD), or received a probable diagnosis of ASD, by a specialist team following Dutch clinical guidelines, confirmed through a recognised diagnostic interview for ASD in adults.

Who may not be able to join:

People who have another mental health condition that currently requires urgent treatment and would significantly interfere with participating in a group-based program (for example, psychosis).
People who have a major condition affecting memory, thinking, or brain function (for example, dementia or acquired brain injury).
People who have a substance use disorder that requires a medically supervised detoxification program.
People whose IQ has been assessed as below 70.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tilburg University

Registry

ClinicalTrials.gov

Start date

12 September 2024

Est. completion

31 March 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Quality of life (MHQoL-7); Acceptance of the diagnosis; Acceptance of the diagnosis from proxy perspective; Knowledge of ASD; Knowledge of ASD from proxy perspective; Recognition of ASD traits; Recognition of ASD traits from proxy perspective; Coping with ASD; Coping with ASD from proxy perspective; Quantitative autistic traits; Quantitative autistic traits from proxy perspective; Resilience; Comorbid psychological distress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov